This project consists of funding structuring equipment for scientific research (notably a laser microdissector, and associated devices) as part of the academic research project “Implementation of predictive biomarkers of relapse in triple-negative breast cancer by integrative and spatial biological approaches”. Triple-negative breast cancer (CSTN; i.e. not expressing estrogen, progesterone and human epidermal growth factor receptor 2 [HER2] receptors, represents 10-20 % of breast cancer.